Paradoxically, TGF-β has two sides to tumor immunity, and it can regulate the expression of tumor cell cycle-related proteins and inhibit cell cycle from exerting anti-tumor effects in the early stage of cancer. The gene discussed is TGFB1; the disease is neoplasm.